The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients

The risks associated with in vivo and ex vivo use of Campath-1H and -1G in a cohort of 206 stem cell transplant recipients for cytomegalovirus (HCMV) DNAemia have been quantified. DNAemia showed a biphasic incidence pattern with an inflexion at day 60. The first phase had a linear risk rate for HCMV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Buyck, Hubertus C, Prentice, H Grant, Griffiths, Paul D, Emery, Vincent C
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829098/
https://ncbi.nlm.nih.gov/pubmed/19966846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2009.329
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados